Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...
The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...
Nichola Hawes is on trial for alleged fraud and selling or supplying medicines without proper prescriptions.
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some patients taking weight-loss drugs lose muscle at far faster rates than those ...
A charity boss who once tipped the scales at more than 28st says weight-loss injections have changed the way he thinks about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback